Replies to post #10 on Nxstage Medical, Inc. (NXTM)

[surf1944]

8:07AM Nxstage Medical announces CE Mark approval, first clinical use of its single needle for dialysis patients (NXTM) 11.27 : Co announced its single needle technology, OneSite, has received CE Mark approval. In addition, initial patient experiences using this new product have demonstrated its benefits for dialysis patients.

As the requirement for certain medical devices to be sold in the European Union, this CE Mark approval will enable NxStage to make OneSite available in countries where it currently distributes its products, including the United Kingdom, the Nordic countries, Benelux, France, and Italy. Separately, NxStage has also received approval to market this product in Canada.